HIV vaccine candidate from Scripps Research starts human testing

The early stage human test is sponsored by the International AIDS Vaccine Initiative, or IAVI, which operates the center at Scripps Research. It will evaluate safety, along with the vaccine candidate’s ability to begin the initial stages of a powerful antibody response to neutralize a broad spectrum of HIV strains.